Business Wire

ABB to Invest €100 Million in Global Innovation and Training Campus

Del

One year after announcing its acquisition of B&R (Bernecker + Rainer Industrie-Elektronik GmbH), ABB is to invest €100 million in Austria to build a state-of-the-art innovation and training campus at the home of B&R in Eggelsberg, Upper Austria. It is the largest organic investment in industrial automation in ABB’s more than 130-year history and lays the foundation for around 1,000 new high-tech jobs in Austria.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180406005249/en/

ABB to invest €100 million in global innovation and training campus in Austria (Graphic: Business Wi ...

ABB to invest €100 million in global innovation and training campus in Austria (Graphic: Business Wire)

The new innovation and training campus will develop technologies for the factory of the future, based on ABB AbilityTM, in which production will be undertaken autonomously by smart and cloud-connected machines and robots. With this investment, ABB is delivering on its Next Level strategy, which defines innovation as a key driver of profitable growth. The company invests $1.4 billion in R&D annually, and has a team of around 30,000 R&D and application engineers. B&R has more than 1,000 employees working in R&D and application development.

The new research and development campus will cover 35,000 m² and be home to a significant number of state-of-the-art facilities. Alongside ultra-modern R&D laboratories, which will develop and test new automation technologies, from industrial control systems up to machine learning and artificial intelligence, there will be an Automation Academy to train and educate customers, partners and employees in these technologies. The ground-breaking ceremony is planned for this summer, and the new campus is expected to be up and running in the course of 2020. Once complete, the Eggelsberg site will be one of ABB’s largest research and development centers.

With the new campus, the world’s second-largest provider of industrial automation solutions will further expand its leadership position in machine and factory automation. The development of disruptive technologies will enable ABB to better serve the highly attractive $20-billion machine and factory automation market segment.

ABB acquired B&R, then the largest independent provider of product- and software-based open-architecture solutions for machine and factory automation worldwide, in July 2017. Today, B&R is integrated into ABB’s Industrial Automation division as its global Machine & Factory Automation business unit. With the combined portfolios, ABB is today the only industrial automation provider offering customers the entire spectrum of technology and software solutions around measurement, control, actuation, robotics, electrification and digitalization.

“B&R has had an excellent start within ABB and has exceeded our expectations. We are well on track to achieve our goal of revenues of more than $1 billion soon,” said ABB CEO Ulrich Spiesshofer, at a press conference in Linz with the Austrian Chancellor, Sebastian Kurz. “With our €100 million investment, we are strengthening this dynamic and the pillars of this success story: innovation and people. In addition to the new research and development capacity, our investment will expand B&R’s Automation Academy, offering customers, partners and employees globally unique education and training programs.”

“With this clear commitment to the Eggelsberg location, ABB has established itself as the market leader in automation in Austria,” said Chancellor Sebastian Kurz. “True to its word, the company is now making an investment that is of tremendous importance to Austria as a business location of international standing. This is the starting signal for a location offensive in the key segment of digital industry. It is an important impulse for the creation of highly qualified new jobs and the positioning of Austria as a high-tech location.”

This will also be beneficial for the country`s educational landscape. “Further strengthening our good relationships with universities, universities of Applied Sciences and higher technical education institutes is part of our innovation and research strategy. This way we can further accelerate our speed of growth and innovation as well as extend our technology leadership,” said Hans Wimmer, Managing Director of B&R.

“This is a great day for B&R,” said Josef Rainer, Co-founder of Bernecker & Rainer Industrie-Elektronik GmbH. “The smooth integration shows that the company Erwin Bernecker and I founded 39 years ago is in excellent hands. I am delighted that ABB continues to write and accelerate our success story with this historic investment.”

ABB (ABBN: SIX Swiss Ex) is a pioneering technology leader in electrification products, robotics and motion, industrial automation and power grids, serving customers in utilities, industry and transport & infrastructure globally. Continuing a history of innovation spanning more than 130 years, ABB today is writing the future of industrial digitalization with two clear value propositions: bringing electricity from any power plant to any plug and automating industries from natural resources to finished products. As title partner of Formula E, the fully electric international FIA motorsport class, ABB is pushing the boundaries of e-mobility to contribute to a sustainable future. ABB operates in more than 100 countries with about 135,000 employees. www.abb.com

Note: This is a translation of the German press release of ABB from April 6, 2018, available at www.abb.com/news. In case of discrepancies, the original German version applies.

Contact information

Media Relations
Phone: +41 43 317 7111
Email: media.relations@ch.abb.com
or
Investor Relations
Phone: +41 43 317 71 11
Email: investor.relations@ch.abb.com
or
ABB Ltd
Affolternstrasse 44
8050 Zurich
Switzerland

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Florian Winterstein Becomes New CEO of Jedox21.9.2018 15:46Pressemelding

The supervisory board of Jedox AG, a leading vendor of business intelligence and enterprise planning software, has appointed Florian Winterstein as Chief Executive Officer (CEO) effective October 2, 2018. This nomination will support Jedox’s international growth and a new development phase initiated by its latest fund raising in April 2018 with Iris Capital, eCAPITAL entrepreneurial Partners AG and Wecken & Cie. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005416/en/ Florian Winterstein (Photo: Business Wire) With 25 years of experience in strategy consulting and leadership in software and service organizations, Winterstein brings to the company a valuable combination of expertise in cloud solutions, business development, and value creation for customers and partners. As former Chief Strategy Officer of BravoSolution, he positioned the software-as-a-service company as trendsetting digitalization partner, extending it

Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 13:30Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+

Asda Selects HCL Technologies to Help Drive IT Transformation21.9.2018 12:16Pressemelding

HCL Technologies (HCL), a leading global technology company, today announced that it has been selected to help drive IT transformation at the UK’s third-largest grocery retailer, Asda. The three-year application services contract will see HCL transform Asda’s IT Application Services with a new DevOps delivery model to drive data and analytics and support back-office applications through the full lifecycle of development, testing and support. HCL will also build a central data management platform to enable Asda to improve its insight and analytics capabilities. Asda operates more than 600 stores across the UK, employing over 135,000 people. Asda wanted to adopt a more agile approach towards application development and testing. This would allow the company to respond faster to business requirements and reduce time to market, while driving better user experience and satisfaction. HCL was selected due to its extensive expertise in successfully delivering similar large scale IT transformati

Ipsen Receives Positive CHMP Opinion for Cabometyx® (Cabozantinib) for the Second-line Treatment of Patients with Hepatocellular Carcinoma (HCC)21.9.2018 05:30Pressemelding

Regulatory News: Ipsen (Euronext:IPN; ADR:IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), provided a positive opinion for Cabometyx® (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have been previously treated with sorafenib. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for the European Union (EU). Alexandre Lebeaut, MD, Executive Vice President, R&D and Chief Scientific Officer, Ipsen, said: “The global burden of liver cancer is increasing and despite the recent introduction of new agents, it remains the second leading cause of cancer mortality worldwide. Following today’s positive CHMP opinion and if approved by the European Commission, Cabometyx ® as monotherapy will give patients with HCC a much-needed new oral therapeutic option.” Dr Lorenza Rimassa,

Quanergy Selected as Exclusive LiDAR Partner for VRCO21.9.2018 05:00Pressemelding

Quanergy Systems, Inc., a global leader in the design and development of solid state LiDAR sensors and smart sensing solutions, and VRCO, designer and manufacturer of the luxury high-end e-VTOL (electric Vertical Take-Off and Landing) craft, the NeoXcraft XP2, today announced that VRCO will exclusively use Quanergy’s S3 solid state LiDAR sensors in the testing and market release versions of the aircraft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006036/en/ VRCO NeoXcraft XP2 with Quanergy S3 LiDAR Sensor (Graphic: Business Wire) The NeoXcraft XP2, which VRCO and the University of Derby unveiled in late 2017 and intend to launch in 2020, is a two-passenger e-VTOL high-speed land, air, and water capable craft. The craft can scan and memorize take-off locations and store the data for use on the next approach to the same location. Quanergy’s innovative S3 solid state LiDAR sensor will be used for downward and forward

Overseas Roadshow for the IAPH Guangzhou 2019 World Ports Conference Was Held in London21.9.2018 03:08Pressemelding

Overseas roadshow for the IAPH Guangzhou 2019 World Ports Conference was successfully held in Armourer's Hall, London, UK on September 20th. Ms. Yuan Yue, Deputy Director General of Guangzhou Port Authority, met with over 100 senior representatives from British ports, ship-owners, commodity traders, shipping & service companies, shipping public policy research institutes, and other representatives from the port and shipping industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006031/en/ Speech made by Lord Jeffrey Evans, Chairman of Maritime London (Photo: Business Wire) In her keynote speech, Ms. Yuan Yue said, “Guangzhou is the gateway city of South China and is known as the “Millennium Business Capital” and a popular destination for business and investment. At present, Guangzhou has attracted investors from over 130 countries. Nearly 300 of the world's top 500 companies have businesses and investment in Guangzho